Top Markets
Coin of the day
Sionna Therapeutics, Inc. Sionna Therapeutics, Inc.

Sionna Therapeutics, Inc.

SION
Rank in Stocks #16567
Operating as a biopharmaceutical company, Sionna Therapeutics, Inc. is... Operating as a biopharmaceutical company, Sionna Therapeutics, Inc. is dedicated to transforming the treatment landscape for individuals with cystic fibrosis. This is achieved by developing innovative medicines designed to restore the normal function of the cystic fibrosis transmembrane conductance regulator.
Share Price
$6.36
Last synced: 2026-09-01
Market Cap
$287.06M
Change (1 day)
5.44%
Change (1 year)
-74.96%
Country
US
Trade Sionna Therapeutics, Inc. (SION)

Category

Operating Margin for Sionna Therapeutics, Inc. (SION)
Operating Margin as of 2026 TTM: 0.00%
According to Sionna Therapeutics, Inc. latest financial reports and stock price the company's current Operating Margin (TTM) is 0.00%. At the end of 2026 the company had an Operating Margin of 0.00%.
Operating Margin history for Sionna Therapeutics, Inc. from 2026 to 2026
Operating Margin at the end of each year
Year Operating Margin Change
Not enough data for the provided dates.
Operating Margin for similar companies or competitors
Company Operating Margin Operating Margin Difference Country
38.59% -
US
28.81% -
NL
-149.01% -
US
25.57% -
AU
0.00% -
CH
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.